The individual roles and overlapping functionalities the twelve human caspases have during apoptosis and other cellular processes remain poorly resolved primarily due to a lack of chemical tools. Here we present a new selective caspase-3 inhibitor, termed Ac-ATS010-KE, with rapid and irreversible binding kinetics. Relative to previously designed caspase-3-selective molecules that have tremendously abated inhibitory rates and thus limited use in biological settings, the improved kinetics of Ac-ATS010-KE permit its use in a cell-based capacity. We demonstrate that Ac-ATS010-KE prevents apoptosis with comparable efficacy to the general caspase inhibitor Ac-DEVD-KE and surprisingly does so without side-chain methylation. This observation is in contrast to the well-established peptide modification strategy typically employed for improving cellular permeability. Ac-ATS010-KE protects against extrinsic apoptosis, which demonstrates the utility of a thiophene carboxylate leaving group in biological settings, challenges the requisite neutralization of free carboxylic acids to improve cell permeability, and provides a tool-like compound to interrogate the role of caspase-3 in a variety of cellular processes.Cell Culture. Jurkat A3 cells were cultured as described by ATCC using 10% FBS and pen/strep/glutamine at 37 °C with 5% CO2. For all experiments, Jurkat cells were grown to near confluence, harvested and resuspended in fresh media to the indicated density. Apoptosis was induced using 10 ng/mL MegaFasL (AdipoGen® Life Sciences).Apoptotic protection assays. Cells were plated into sterile Nunc Edge 96-well tissue culture-treated plates at a density of 10,000 cells/well and preincubated (or chased) with 20 µM of the indicated inhibitor or DMSO vehicle for the indicated time before (or after) apoptotic induction. 3 h after induction, cellular viability was measured using CellTiter-Glo® on a PerkinElmer EnVision plate reader.